Background. Cell-free DNA (CFDNA) in the plasma/serum of patients with cancer
INTRODUCTION
Cell-free circulating DNA (CFDNA) has been studied in a wide range of physiological and pathological conditions, including pregnancy, trauma, inflammatory disorders and malignancy [1, 2] . It is present in normal healthy individuals at low concentrations (ng/ml) [3] . Raised levels of CFDNA in cancer patients have been reported in many tunour types [2] [3] [4] [5] . The finding that genetic and epigenetic changes typical of tumours can be detected in CFDNA from cancer patients, suggests that the excess CFDNA is of tumour origin. Although the precise mechanism of DNA release into the blood remains uncertain, it probably derives from a combination of apoptosis, necrosis and active release from tumour cells [6] . Such cell-free DNA has shown promise for improving early clinical diagnosis, prognostication and disease monitoring in inaccessible tumour types, such as lung cancer [7] [8] [9] [10] [11] .
Although higher levels of CFDNA are consistently reported in cancer patients than healthy controls, there is considerable variation between studies. This may be attributable to differences in study design including selection of patient and control groups, and the methods used to extract and quantify CFDNA [10, [12] [13] [14] . No agreed standards exist, and many publications fail to specify how samples were obtained, processed and analysed. The problems of prolonged sample storage have been highlighted by a recent report that DNA levels in plasma stored at -80 o C declined by 30% per year [15] . Thus, this study was designed to evaluate the factors most likely to influence the yield of CFDNA from clinical samples.
Various methods have been used to purify CFDNA, including using modified saltingout [16] , chromatography resins [16, 17] , magnetic beads [18] , or guanidium thiocyanate [19] . The most popular is the QIAamp blood kit, which binds DNA to a silica-gel membrane, providing a fast and easy way to purify total DNA for polymerase chain reaction (PCR) analysis. We found that the recovery of CFDNA was less than 20% using the QIAamp DNA Midi Kit. Some authors have recommended using a predigestive buffer in plasma/serum samples to improve the results [16, 18, 20] . Therefore, we have evaluated standard and modified QIAamp protocols and compared them with a simple Triton/Heat/Phenol (THP) protocol.
Because DNA is present in plasma/serum at such low concentrations (ng/ml), it is crucial to optimize laboratory protocols for the processing and extraction of CFDNA.
MATERIALS AND METHODS

Sample collection and preparation
To compare different CFDNA extraction protocols, commercial pooled human serum (SLI Ltd, UK) was spiked with reference genomic DNA (Sigma-Aldrich, UK) or a known amount of linearised bcl-2 plasmid reference DNA (final concentration in serum: 0, 50 and 100 ng/ml). For clinical samples, 20 ml peripheral blood was collected from healthy volunteers into EDTA tubes [21] . Plasma was separated by double centrifugation (800g for 10 min, separation, and 1600g for 10 min). Plasma aliquots were immediately frozen at -70 o C.
CFDNA extraction
For the standard QIAamp method, DNA was purified using the QIAamp Blood DNA Midi Kit (Qiagen, UK) in accordance with the manufacturer's instructions. The The quality of the purified DNA was checked by conventional PCR amplification of the p53 gene. To determine if the different DNA extraction methods led to loss of small DNA fragments, the Quick-Load® 100 bp DNA Ladder (New England Biolabs, UK) was spiked into pooled human serum. After re-purification, the ladder DNA was analyzed on 1.5% agarose gels with 0.5 µg/ml ethidium bromide.
Quantitative analysis of DNA
Quantification of total DNA was performed using the PicoGreen assay (Molecular Probes, Netherlands) following the manufacturer's instructions. Genomic (hGAPDH) [22] and plasmid (bcl-2) DNA were analyzed by SYBR-Green I fluorescence real-time PCR with an ABI7900 Sequence Detection Instrument (Applied Biosystems, USA).
Melting curves of all tubes were observed for every reaction to ensure that only one product was present. All samples were performed in triplicate and the mean value was used for quantification. The qPCR efficiency was calculated from the slope of the 
Statistical analysis
Quantitative results were presented as mean ± standard deviation (SD). Differences were evaluated by two-tailed unpaired t-test (p-value) and correlations were evaluated using the Pearson correlation coefficient (r). The reproducibility of different protocols was evaluated by coefficient of variation (CV). The effects of time delay during blood sample processing on CFDNA concentration were analyzed by two-way ANOVA with interaction. GraphPad Prism 4.03 software was used for statistical analysis.
RESULTS
Optimization of QIAamp protocol
Digesting or denaturing the plasma/serum proteins is one of the most important stages during the extraction of CFDNA. We compared the protease provided in the QIAamp Blood Kit with proteinase K for the purification of low quantities of CFDNA. 
Evaluation of THP protocol for DNA extraction
In our initial studies, the recovery of CFDNA from plasma or serum with the QIAamp Midi Kit was less than 20%. We therefore evaluated the simple THP protocol. Pooled human serum was spiked with different amounts of genomic DNA and heated at 98 o C for 5 minutes, then direct PCR was performed on 5 µl samples using primers for the p53 gene. The lowest spiked concentration was 25 ng/ml and generated positive products consistently. No significant improvement was achieved by using a different protein digestion buffer (data not shown). Phenol extraction was used to obtain purified DNA solution for further analysis requiring good-quality DNA templates. Since CFDNA exists in fragments of varying size and QIAGEN columns might lose small DNA fragments (<150bp) [20] , we checked the ability of THP procedure to extract DNA fragments of different sizes. Figure 3A shows that fragments as small as 100bp were consistently obtained using THP method. It is 8 essential that DNA extraction methods used for CFDNA yield purified DNA of sufficient quality for PCR analysis. Figure 3B shows that DNA extracted using the THP protocol from human serum spiked with 50 ng/ml and 200 ng/ml genomic DNA was suitable for PCR amplification of the p53 gene. methods. We were initially surprised to obtain DNA yields of less than 20%, but a detailed literature review showed that this was not unusual [16, 17] . There is clearly a need to optimize DNA extraction from clinical samples where it is present at such low levels. Very low amounts of CFDNA have been found in healthy individuals, although some authors consider it undetectable in plasma [25] . We therefore spiked the pooled serum samples of healthy individuals with reference DNA for our studies, to achieve levels of CFDNA comparable to those reported in cancer patients [10] .
Comparison of the THP and standard QIAamp methods
A number of different methods have been used to quantify CFDNA, including DNA dipsticks, the PicoGreen double-stranded DNA assay, dot-hybridization or nick translation [10] . More recently, quantitative real-time PCR (QPCR) methods have been widely used including SYBR green, Taqman and allele specific real time PCR.
These methods have varying specificity and sensitivity [22] . Here we chose to use the PicoGreen and SYBR green assays to combine adequate sensitivity within the expected concentration range, with robust and easily optimised assays.
Although the QIAamp blood kit is the most popular method for extracting CFDNA, it does not appear very efficient at such low DNA concentrations. We sought to increase its efficiency by pre-incubating samples with a different protease to remove proteins. Proteinase K is a subtilisin-type protease particularly suitable for short digestion times. The predominant site of cleavage is the peptide bond adjacent to the carboxyl group of aliphatic and aromatic amino acids with blocked alpha amino groups. Raising the temperature of proteinase K from 37 o C to 50-60 o C can increase its activity several fold [23] . We found that proteinase K was more efficient than QIAgen protease, and that incubation at 37 o C gave better results than RT or 50 o C on CFDNA purification. One potential explanation is that higher temperature and longer incubation times accelerate DNA degradation or fragmentation and its impact cannot be made up by the increased activity of protease. We also tested another SDScontaining buffer recommended by Schmidt et al [20] , but discovered that molecular grade SDS from several manufacturers is contaminated with variable amounts of DNA (results not shown). Hence this method cannot be recommended for the extraction of CFDNA.
We studied the effects of varying the type, temperature and volume of elution buffer in the QIAamp protocol. Some authors use small volumes of elution buffer (50µl) to obtain a concentrated DNA solution for subsequent PCR analysis [24, 26] . However, we found that using low volumes of elution buffer led to a significantly lower DNA yield. The yield could be significantly improved by eluting twice using two volumes of 200µl and 100µl, successively. However, the dilution in 300µl might have rendered low CFDNA concentrations undetectable, leading to false-negative PCR results. We found no obvious difference when using distilled water or AE buffer, at RT or 40 o C.
Because buffer AE has the potential to inhibit PCR reactions, sterile distilled water is preferred as elution buffer [27] .
In the THP protocol, 98 o C incubation was used to inactivate PCR inhibitors and denature proteins in plasma/serum samples. Different times and temperatures were tested before choosing this. Since we had noticed substantial DNA contamination in SDS, Triton X-100 was used in the protein solubilization step. Direct conventional PCR was performed successfully on heat-denatured samples and able to detect 25 ng/ml DNA, indicating that this simple procedure offered sufficient protein digestion and inhibitor elimination for PCR analysis. The THP protocol gave a significantly higher yield of pure DNA solution for qPCR analysis than the QIAamp kit. The THP protocol showed high efficiency even with small DNA fragments as low as 100 bp.
The abilities of these protocols to extract the CFDNA were evaluated by quantitive
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PCR. This showed that the THP products were more reproducible and consistent than the standard QIAamp protocol. In addition it is simple, relatively cheap and easy to perform and standardise. Phenol can present risks to the user, including burns on contact with the skin or mucous membranes, and carcinogenicity. It is therefore important to adhere to stringent protocols for its safe use in the laboratory. However, laboratory staff working with very low levels of DNA in human plasma and serum samples are familiar with careful procedures to avoid contamination of samples, and the risk of spillages in this setting is low.
The way clinical blood samples are handled before reaching the laboratory has significant impact on CFDNA yields. These findings will therefore be important in designing our future clinical studies. We found that recovered CFDNA from blood samples kept at RT was comparable to the samples on ice processed at same time intervals (0 to 25 hours), which is consistent with other observations [27, 28] .
However, delays in separating the plasma could increase the amount of recovered DNA. This contradicts the observations of Jung et al [28] , who reported that the DNA concentration in plasma did not change when blood samples were stored at RT for 8 and processing time should be specified in study protocols and taken into account during data analysis. We are now using this methodology in a study of CFDNA from lung cancer patients and controls. 
